Code of Ethics | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Code of Ethics

Introductory image: Patient and Doctor Wearing Masks at Hospital

This Statement of Values and Code of Ethics outlines the values and ethical standards that are the basis for every decision made by our Board of Directors, staff and volunteers.

AAMDSIF has a distinct and prominent responsibility to adhere to the highest possible ethical standards. This document is intended as a supplement to the obligations of the AAMDSIF Board, committees, and staff members provided in the AAMDSIF Statement of Fiduciary Responsibility.

AAMDSIF hopes that this statement will demonstrate - in clear, easy-to-understand terms - its ongoing commitment to the core values of integrity, honesty, dignity, fairness, openness, respect and responsibility.

AAMDSIF does not discriminate on the basis of race, color, religious creed, gender, national origin, age, physical ability, sexual orientation, income level, marital status or veteran status in the conduct or provision of services.

Statement of values

In carrying out its mission, the Foundation and its Board members, staff and volunteers shall endeavor to act with the following values:

  • Accountability and commitment to the good of patients, caregivers and families dealing with bone marrow failure disease
  • Respect for the worth and dignity of all individuals
  • Dedication to inclusiveness and diversity
  • Commitment to transparency, integrity and honesty in all dealings
  • Responsible stewardship of resources

Code of ethics

I.    Personal and Professional Integrity
All AAMDSIF Board members, staff, and volunteers will act with honesty and openness in all of their dealings as representatives of the Foundation.  AAMDSIF operates in a working environment that values the highest ethical values and integrity.

II.    Mission

AAMDSIF is dedicated to:

  • Serving as the resource of choice for patient assistance, advocacy and support
  • Providing educational materials and medical information
  • Promoting public awareness and understanding of bone marrow diseases
  • Funding research to find treatments and cures for aplastic anemia (AA), myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and related bone marrow diseases

All AAMDSIF programs are designed to support this mission, and all individuals who work for or on behalf of AAMDSIF must understand and remain loyal to this mission.

III.    Governance

AAMDSIF is governed by a volunteer Board of Directors which is responsible for setting the mission and strategic direction of the Foundation and providing oversight of the finances, operations and policies of the organization. Members of the Board of Directors are not compensated for their time and work with AAMDSIF. The Board of Directors endeavors to ensure that:

  • The Board of Directors will be comprised of patients, caregivers and family members of patients.
  • No individual shall be nominated for, or elected to, the AAMDSIF Board of Directors because of his or her affiliation with any private interests, including but not limited to, pharmaceutical companies.
  • Private interests, including pharmaceutical companies, will have no influence on the governance of AAMDSIF.
  • The members of the AAMDSIF Board of Directors are committed to furthering the best interests of AAMDSIFand those it serves.
  • Each year, all Board members sign a Disclosure Statement and Acknowledgment identifying any organizations or companies with which they are involved which might present an actual or apparent conflict of interest with their service as fiduciaries of AAMDSIF. Members have also agreed to disclose any such actual or apparent conflicts to the Board and to recuse themselves from any vote or discussion in such circumstances unless otherwise directed by the Board.
  • All transactions and dealings will be conducted with integrity and honesty.
  • No staff or Board member of AAMDSIF is employed by, or serves as a volunteer or consultant in any capacity with, any pharmaceutical company or any other for-profit corporation that is likely to receive a direct benefit from relationships with AAMDSIF or the patients that it serves.
  • The CEO and staff will provide the Board with timely and comprehensive information so that the Board can effectively carry out its governance duties.
  • AAMDSIF will promote working relationships among the Board, staff, volunteers and AAMDSIF beneficiaries based on mutual respect, fairness and openness.
  • AAMDSIF's policies will be clearly written, officially adopted and adhered to.
  • The resources of AAMDSIF will be used responsibly and prudently so that AAMDSIF has the capacity to carry out its programs effectively.
  • A distinguished and internationally-respected Medical Advisory Board will advise the Board of Directors on decisions about grants for research and will review medical information before publication by AAMDSIF.

IV.    Legal Compliance
The Board members, staff, and volunteers of AAMDSIF are committed to observing all applicable federal, state, and local laws and international conventions.

V.     Responsible Stewardship

The Board and staff of AAMDSIF are committed to managing the Foundation's funds responsibly and prudently by:

  • Designing a plan and budget that devotes as much as possible to programs that serve its mission
  • Ensuring that all spending practices and policies are fair, reasonable and appropriate to fulfilling the mission of AAMDSIF
  • Never allowing any donor or donation to compromise the ethical standards of AAMDSIF or cause it to deviate from its core mission
  • Never advertising, marketing or promoting a commercial product or service offered by any of its donors
  • Preparing regular financial reports that are factually accurate and complete in all material aspects
  • Having annual financial audits conducted by an outside and professionally recognized accounting firm, ensuring that financial operations adhere to IRS regulations and general accounting principles
  • Ensuring that basic financial documents are available to the public

VI.     Openness and Disclosure
AAMDSIF's Board and staff are committed to providing comprehensive information to the public, the media and all stakeholders and to being responsive in a timely manner to all reasonable requests for information. The Board and staff shall endeavor to ensure that all financial, organizational and program reports will be complete and accurate.

VII.    Fundraising

AAMDSIF's Board and staff are committed to being truthful in all fundraising materials, respecting the privacy concerns of individual donors, expending funds consistent with donor intent and disclosing important and relevant information to potential donors. AAMDSIF's Board and staff respect the right of donors to:

  • Be informed of the organization's mission, how resources are used and the ability of AAMDSIF to use donations effectively for intended purposes
  • Have access to the organization's most recent financial reports
  • Be assured that gifts will be used for the purposes for which they were given
  • Receive appropriate acknowledgement and recognition
  • Be assured that information about their donations is handled with respect and with confidentiality as required by law
  • Be informed whether individuals seeking donations are volunteers, employees or hired solicitors
  • Receive prompt, truthful and forthright answers to any questions about donations

Some of the unrestricted educational grants that AAMDSIF receives are from pharmaceutical companies. Such grants are used to support the mission of AAMDSIF. While the Foundation accepts such grants, AAMDSIF does not agree to provide or grant donors with any special access to AAMDSIF Board members, staff, constituents, Medical Advisory Board members, volunteers or other officials. These grants do not entitle the donor to any influence on organizational or program policies or on the awarding of research grants. These grants do not influence the educational and informational materials distributed by the Foundation. AAMDSIF will not endorse any drug or treatment on the basis of the receipt of a grant or donation from a pharmaceutical company or any other private entity.

VIII.    Privacy

AAMDSIF keeps private and confidential all information that it collects or receives about patients and family members.  Personal patient information will only be used in the aggregate for demographic purposes.  Except as required by law, AAMDSIF will never provide information about its donors to any other group or persons, nor will it advertise, market, or promote a commercial product or service offered by any donor.